NYSE: RHE - Regional Health Properties, Inc.

Yield per half year: +16.59%
Dividend yield: 0.00%
Sector: Healthcare

Regional Health Properties, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.74 -100% -1.44 -100%
P/S 0.2286 4.12 -94.45%
P/BV 21.21 11.03 92.23%
P/FCF 1.96 40.86 -95.2%
Ev/Ebitda 36.8 18.21 102.08%
Ev/S 3.11 4.41 -29.48%
Ev/FCF 19.39 53.38 -63.68%
E/P -0.72 0.2141 -436.35%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
3/10
8.45 21 -59.74% 15.63 -45.9%
ROE -2101.63 -82.13 2459.06%
ROA -6.25 6.93 -190.18%
ROIC 0 15.68 -100%
ROS -22.65 10.96 -306.67%
ROCE -434.59 85.54 -608.06%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
36.75 1.69 2078.07% 28.13 +30.65%
Nеt Debt/Ebitda 34.09 2.06 1555.04%
Debt/Ratio 0.8576 0.2715 215.93%
Debt/Equity 335.11 15.66 2040.52%
Debt/Net Income -13.72 6.36 -315.57%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.27 -100% 4.53 -100%
Number of years of dividend growth 1 6.68 -85.04%
DSI 0.5 0.7209 -30.64%
Average dividend growth 0 -2.16 -100%
Average percentage for 5 years 4.53 1.31 245.35%
Average percentage for payments 0 49.71 -100%
Difference from average difference in sector -1.27

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-14.61 84.08 -117.38%
Growth impulse Ebitda in 5 years -83.7 81.8 -202.32%
Growth impulse Net Income in 5 years -138.12 150.77 -191.61%
Growth impulse FCF in 5 years 19.74 56.79 -65.24%
Growth impulse EPS in 5 years -134.35 71.08 -289.01%
IP Score
2.45/10

Similar companies

Varian Medical

Evolent Health

Boston Scientific

Mallinckrodt public limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription